Evogene Set To Raise $86M On NYSE

November 12, 2013 | Israeli plant genomics company Evogene, which develops genetically enhanced seeds for better crop performance, has announced the terms for its public offering to be held on the New York Stock Exchange (NYSE) today. The company will offer 5 million shares $17.16, with the aim of raising $86 million.